For example, Wing et al. designed folate receptor alpha (FR-α) targeting T cell engager CAR-T cells (anti-EGFR BiTEs) and showed that anti-EGFR BiTEs increased the anti-tumor efficacy of anti-EGFR CAR-T cells in a mouse model of glioblastoma [53]. This evidence concerns the gene EGFR and glioblastoma.